Results 21 to 30 of about 111,576 (246)
Management of acute attacks of hereditary angioedema: potential role of icatibant
Vascular Health and Risk Management, 2010 Hilary J LonghurstDepartment of Immunology, Barts and The London NHS Trust, London, UKAbstract: Icatibant (Firazyr®) is a novel subcutaneous treatment recently licensed in the European Union for acute hereditary angioedema. Hereditary angioedema,
Hilary J Longhurst
doaj +1 more source
Management of hereditary angioedema in pregnant women: a review
International Journal of Women's Health, 2014 Teresa Caballero,1,2 Julio Canabal,1 Daniela Rivero-Paparoni,1 Rosario Cabañas1 1Hospital La Paz Institute for Health Research, (IdiPaz) 2Biomedical Research Network on Rare Diseases-U754 (CIBERER), Madrid, Spain Abstract: Three types of ...
Caballero T +3 more
doaj +1 more source
Treatment of hereditary angioedema with plasma-derived C1 inhibitor
Therapeutics and Clinical Risk Management, 2008 Michael J Prematta, Tracy Prematta, Timothy J CraigSection of Allergy and Immunology, Penn State University, Milton S. Hershey Medical Center, PA, USABackground: Plasma-derived C1 inhibitor (C1-INH) concentrate is a treatment option for acute hereditary ...
Michael J Prematta +2 more
doaj +1 more source
Alergologia PolskaHereditary angioedema (HAE) is an autosomal dominantly inherited disease caused by deficiency of C1 esterase inhibitor protein type 1 (about 85% of patients with HAE-C1-INH) or type 2 oedema (about 15% of patients with HAE-C1-INH) by C1 inhibitor ...
Artur Gęsicki +6 more
doaj +2 more sources
Peri-operative management of a pregnant patient with hereditary angioedema submitted to a cesarean-section: case report [PDF]
Revista Brasileira de Anestesiologia, 2020 Hereditary angioedema is an autosomal dominant disorder, presenting as sudden and recurring episodes of variable severity of subcutaneous and mucosa edema that may occur spontaneously or in response to triggers.
Teresa Maria Ramos Nunes Estevens +3 more
doaj +5 more sources
Pediatric hereditary angioedema presenting as recurrent episodic abdominal pain and vomiting: Challenges in diagnosis and management. [PDF]
JPGN RepAbstract Recurrent episodic abdominal pain and vomiting, with symptom‐free intervals between attacks, represent common and often challenging presentations in children, typically leading to extensive workups without a clear etiology, as standard diagnostic algorithms fail to include rare systemic conditions. We present the challenging diagnostic odyssey
Busaniche JN +8 more
europepmc +2 more sources
Romanian Journal of Laboratory Medicine, 2021 Acquired angioedema due to C1-inhibitor deficiency is a very rare disorder that usually appears in patients with lymphoproliferative and/or autoimmune diseases.
Bara Noémi +3 more
doaj +1 more source
Biomarkers in Hereditary Angioedema [PDF]
Clinical Reviews in Allergy & Immunology, 2021 AbstractA biomarker is a defined characteristic measured as an indicator of normal, biologic, pathogenic processes, or biological responses to an exposure or intervention. Diagnostic biomarkers are used to detect a disease or a subtype of a disease; monitoring biomarkers are measured serially to assess a medical condition; response biomarkers are used ...
Grzegorz Porebski +2 more
openaire +2 more sources
Clinical Case Reports, 2021 Subcutaneous plasma‐derived human C1‐Inhibitor concentrate (pdC1INH) may be safe and effective for long‐term prophylaxis during pregnancy and lactation in hereditary angioedema patients.
Shimalee Andarawewa +1 more
doaj +1 more source
Hereditary angioedema: approaches to diagnosis and treatment, analysis of a clinical family case
Медицинский совет, 2021 Hereditary angioedema belongs to the group of rare, orphan, genetically determined defects that represent a significant medical and social problem due to the pronounced impact on the quality of life and potential mortality, as well as the emerging ...
O. V. Skorohodkina +3 more
doaj +1 more source